The elucidation of the VHL-HIF-1α(hypoxia inducible factor-1α)-VEGF (vascular endothelial growth factor) pathway has led to the development of targeted therapy in renal cell carcinoma (RCC). The gene discussed is VEGFA; the disease is hereditary clear cell renal cell carcinoma.